Active induction of experimental allergic encephalomyelitis

Ingunn M Stromnes; Joan M Goverman

doi:10.1038/nprot.2006.285

journal article Nov 01, 2006

Active induction of experimental allergic encephalomyelitis

Ingunn M Stromnes Joan M Goverman

Nature Protocols Vol. 1 No. 4 pp. 1810-1819 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/nprot.2006.285

Topics

No keywords indexed for this article. Browse by subject →

References

134

[1]

Sospedra, M. & Martin, R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23, 683–747 (2005). 10.1146/annurev.immunol.23.021704.115707

[2]

Lucchinetti, C. et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Annu. Neurol. 47, 707–717 (2000). 10.1002/1531-8249(200006)47:6<707::aid-ana3>3.0.co;2-q

[3]

Campbell, I.L., Stalder, A.K., Akwa, Y., Pagenstecher, A. & Asensio, V.C. Transgenic models to study the actions of cytokines in the central nervous system. Neuroimmunomodulation 5, 126–135 (1998). 10.1159/000026329

[4]

Matsushima, G.K. & Morell, P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11, 107–116 (2001). 10.1111/j.1750-3639.2001.tb00385.x

[5]

Ercolini, A.M. & Miller, S.D. Mechanisms of immunopathology in murine models of central nervous system demyelinating disease. J. Immunol. 176, 3293–3298 (2006). 10.4049/jimmunol.176.6.3293

[6]

The T Lymphocyte in Experimental Allergic Encephalomyelitis

S S Zamvil, L Steinman

Annual Review of Immunology 1990 10.1146/annurev.iy.08.040190.003051

[7]

Kuchroo, V.K. et al. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20, 101–123 (2002). 10.1146/annurev.immunol.20.081701.141316

[8]

Koritschoner, R.S. & Schweinburg, F. Induktion von Paralyse und Rückenmarksentzündung durch Immunisierung von Kaninchen mit menschlichem Rückenmarksgewebe. Z. Immunitätsf. Exp. Ther. 42, 217–283 (1925).

[9]

Rivers, T.M., Sprunt, D.H. & Berry, G.P. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J. Exp. Med. 58, 39–53 (1933). 10.1084/jem.58.1.39

[10]

Paterson, P.Y. Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J. Exp. Med. 111, 119–133 (1960). 10.1084/jem.111.1.119

[11]

Kabat, E.A., Wolf, A. & Bezer, A.E. The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvant. J. Exp. Med. 85, 117–129 (1947). 10.1084/jem.85.1.117

[12]

Levine, S. & Sowinski, R. Experimental allergic encephalomyelitis in inbred and outbred mice. J. Immunol. 110, 139–143 (1973). 10.4049/jimmunol.110.1.139

[13]

Martenson, R.E., Deibler, G.E. & Kies, M.W. Microheterogeneity of guinea pig myelin basic protein. J. Biol. Chem. 244, 4261–4267 (1969). 10.1016/s0021-9258(18)94314-0

[14]

Olitsky, P.K. & Tal, C. Acute disseminated encephalomyelitis produced in mice by brain proteolipid (Folch–Lees). Proc. Soc. Exp. Biol. Med. 79, 50–53 (1952). 10.3181/00379727-79-19269

[15]

Poduslo, S.E. Proteins and glycoproteins in plasma membranes and in the membrane lamellae produced by purified oligodendroglia in culture. Biochim. Biophys. Acta 728, 59–65 (1983). 10.1016/0005-2736(83)90436-4

[16]

Lebar, R. & Vincent, C. Tentative identification of a second central nervous system myelin membrane autoantigen (M2) by a biochemical comparison with the basic protein (BP). J. Neuroimmunol. 1, 367–389 (1981). 10.1016/0165-5728(81)90018-7

[17]

Linnington, C., Webb, M. & Woodhams, P.L. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J. Neuroimmunol. 6, 387–396 (1984). 10.1016/0165-5728(84)90064-x

[18]

Ben-Nun, A., Wekerle, H. & Cohen, I.R. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11, 195–199 (1981). 10.1002/eji.1830110307

[19]

Zamvil, S. et al. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317, 355–358 (1985). 10.1038/317355a0

[20]

McDevitt, H.O., Perry, R. & Steinman, L.A. Monoclonal anti-Ia antibody therapy in animal models of autoimmune disease. Ciba Found. Symp. 129, 184–193 (1987).

[21]

Seamons, A., Perchellet, A. & Goverman, J. Immune tolerance to myelin proteins. Immunol. Res. 28, 201–221 (2003). 10.1385/ir:28:3:201

[22]

Wekerle, H., Linnington, H., Lassmann, H. & Meyermann, R. Cellular immune reactivity within the CNS. Trends Neurosci. 9, 271–277 (1986). 10.1016/0166-2236(86)90077-9

[23]

Hickey, W.F. Migration of hematogenous cells through the blood–brain barrier and the initiation of CNS inflammation. Brain Pathol. 1, 97–105 (1991). 10.1111/j.1750-3639.1991.tb00646.x

[24]

Brabb, T. et al. In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. J. Exp. Med. 192, 871–880 (2000). 10.1084/jem.192.6.871

[25]

Tompkins, S.M. et al. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J. Immunol. 168, 4173–4183 (2002). 10.4049/jimmunol.168.8.4173

[26]

Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis

Eileen J McMahon, Samantha L Bailey, Carol Vanderlugt Castenada et al.

Nature Medicine 2005 10.1038/nm1202

[27]

Kawakami, N. et al. The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J. Exp. Med. 199, 185–197 (2004). 10.1084/jem.20031064

[28]

Raine, C. The lesion in multiple sclerosis and chronic relapsing experimental allergic encephalomyelitis: a structural comparison. in Multiple Sclerosis: Clinical and Pathogenetic Basis (eds. Raine, C.S., McFarland, H.F. & Tourtellotte, W.W.) 243–286 (Chapman & Hall, Londan, 1997).

[29]

Stromnes, I.M. & Goverman, J.M. Passive induction of experimental allergic encephalomyelitis. Nat. Protocols doi 10.1038/nprot.2006.284 (2006). 10.1038/nprot.2006.284

[30]

Sobel, R.A. Genetic and epigenetic influence on EAE phenotypes induced with different encephalitogenic peptides. J. Neuroimmunol. 108, 45–52 (2000). 10.1016/s0165-5728(99)00270-2

[31]

Berger, T. et al. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest. 76, 355–364 (1997).

[32]

Linington, C., Bradl, M., Lassmann, H., Brunner, C. & Vass, K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130, 443–454 (1988).

[33]

Waksman, B.H. & Adams, R.D. A comparative study of experimental allergic neuritis in the rabbit, guinea pig, and mouse. J. Neuropathol. Exp. Neurol. 15, 293–334 (1956). 10.1097/00005072-195607000-00005

[34]

Waksman, B.H. The distribution of experimental auto-allergic lesions. Its relation to the distribution of small veins. Am. J. Pathol. 37, 673–693 (1960).

[35]

Rose, L.M., Richards, T. & Alvord, E.C., Jr. Experimental allergic encephalomyelitis (EAE) in nonhuman primates: a model of multiple sclerosis. Lab. Anim. Sci. 44, 508–512 (1994).

[36]

Genain, C.P. & Hauser, S.L. Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus. Immunol. Rev. 183, 159–172 (2001). 10.1034/j.1600-065x.2001.1830113.x

[37]

t Hart, B.A. et al. Modelling of multiple sclerosis: lessons learned in a non-human primate. Lancet Neurol. 3, 588–597 (2004). 10.1016/s1474-4422(04)00879-8

[38]

Lebar, R., Boutry, J.M., Vincent, C., Robineaux, R. & Voisin, G.A. Studies on autoimmune encephalomyelitis in the guinea pig. II. An in vitro investigation on the nature, properties, and specificity of the serum-demyelinating factor. J. Immunol. 116, 1439–1446 (1976). 10.4049/jimmunol.116.5.1439

[39]

Genain, C.P. et al. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate 96, 2966–2974 (1995).

[40]

Schluesener, H.J., Sobel, R.A., Linington, C. & Weiner, H.L. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139, 4016–4021 (1987). 10.4049/jimmunol.139.12.4016

[41]

Adelmann, M. et al. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J. Neuroimmunol. 63, 17–27 (1995). 10.1016/0165-5728(95)00124-7

[42]

Stefferl, A. et al. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the “resistant” Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. J. Immunol. 163, 40–49 (1999). 10.4049/jimmunol.163.1.40

[43]

Iglesias, A., Bauer, J., Litzenburger, T., Schubart, A. & Linington, C. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 36, 220–234 (2001). 10.1002/glia.1111

[44]

Morris-Downes, M.M. et al. Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice. J. Neuroimmunol. 125, 114–124 (2002). 10.1016/s0165-5728(02)00040-1

[45]

Abdul-Majid, K.B. et al. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scand. J. Immunol. 55, 70–81 (2002). 10.1046/j.1365-3083.2002.01024.x

[46]

Oliver, A.R., Lyon, G.M. & Ruddle, N.H. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J. Immunol. 171, 462–468 (2003). 10.4049/jimmunol.171.1.462

[47]

Tsunoda, I., Kuang, L.Q., Theil, D.J. & Fujinami, R.S. Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains. Brain Pathol. 10, 402–418 (2000). 10.1111/j.1750-3639.2000.tb00272.x

[48]

Haase, C.G. et al. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J. Neuroimmunol. 114, 220–225 (2001). 10.1016/s0165-5728(00)00462-8

[49]

O'Connor, K.C. et al. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J. Immunol. 175, 1974–1982 (2005). 10.4049/jimmunol.175.3.1974

[50]

Storch, M.K. et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8, 681–694 (1998). 10.1111/j.1750-3639.1998.tb00194.x

Showing 50 of 134 references

Cited By

476

Multiple sclerosis: etiology in the context of neurovascular unit and immune system involvement and advancements with in vitro blood–brain barrier models

Aya A. El-Taibany, Parichehr Heydarian · 2025

Frontiers in Immunology

The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming

Sophia M. Hochrein, Hao Wu · 2022

Cell Metabolism

Multiple sclerosis and myelin basic protein: insights into protein disorder and disease

Vebjørn Martinsen, Petri Kursula · 2021

Amino Acids

Neuronal interleukin-1 receptors mediate pain in chronic inflammatory diseases

Benoit Mailhot, Marine Christin · 2020

Journal of Experimental Medicine

IL-17 induced NOTCH1 activation in oligodendrocyte progenitor cells enhances proliferation and inflammatory gene expression

Chenhui Wang, Cun-Jin Zhang · 2017

Nature Communications

Passive induction of experimental allergic encephalomyelitis

Ingunn M Stromnes, Joan M Goverman · 2006

Nature Protocols

Metrics

476

Citations

134

References

Details

Published: Nov 01, 2006
Vol/Issue: 1(4)
Pages: 1810-1819
License: View

Authors

Cite This Article

Ingunn M Stromnes, Joan M Goverman (2006). Active induction of experimental allergic encephalomyelitis. Nature Protocols, 1(4), 1810-1819. https://doi.org/10.1038/nprot.2006.285

Active induction of experimental allergic encephalomyelitis

You May Also Like